AQP9 and hepatocellular carcinoma: Our findings revealed that SKL2001 could reverse the effects caused by overexpressed AQP9 during the development of HCC, suggesting AQP9 may function as a tumor suppressor via suppressing Wnt/β-catenin signaling.